AXSM
AXSM
US05464T1043
Axsome Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
8.82B EUR
12.8B EUR
8.69B EUR
Enterprise Value
8.81B EUR
12.71B EUR
8.61B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
35.8x
--
--
Price to Sales
11.36x
16.48x
12.27x
Price to Book
105.68x
153.67x
159.22x
EV/Revenue
11.35x
16.36x
12.15x
EV/EBITDA
-50.97x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-0.05%
-0.56%
-0.82%
ende